+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 15Years +
FEMALE
ID07616739

Evaluating the Safety and Effectiveness of DolutegravirLamivudine Compared to Other Regimens in Pregnant Women with HIV-1

Led by Fundación Huésped · Updated on 2026-09-18

210

Participants Needed

10

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the effectiveness and safety of Dolutegravir combined with Lamivudine compared to other antiretroviral regimens in pregnant women who have HIV-1 and have not received prior treatment. The study focuses on how well these treatments reduce the viral load in mothers and prevent HIV transmission to their newborns. It also looks at maternal side effects, birth outcomes, immune system changes, and resistance to treatment during pregnancy. Participants receive one of two drug regimens Dolutegravir plus Lamivudine taken once daily as a single tablet, or Dolutegravir combined with either TenofovirEmtricitabine or TenofovirLamivudine daily tablets. The study is randomized and open-label, meaning participants are assigned to groups by chance without placebo, and treatment is observed openly. Treatment continues through pregnancy until six months after delivery, with monitoring of viral load and other health indicators. During the study, participants will have regular visits for blood tests measuring viral load, immune cell counts, drug resistance, and safety labs. The babies will be tested at birth, six weeks, and six months to check for HIV infection. Researchers will track maternal weight gain, pregnancy outcomes, side effects, and whether the women need to change their treatment before delivery. The total involvement lasts about 14 months, depending on when participants join during pregnancy.

CONDITIONS

Brief Title

Dolutegravir/Lamivudine in Treatment-Naïve Pregnant Women

Research Team

M

María Inés Figueroa, MD

E

Emanuel Dell'Isola, Mr.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here